Major study aims to crack the code on devastating transplant complication
NCT ID NCT00637689
Summary
This study aims to improve how doctors measure and understand chronic graft-versus-host disease (GVHD), a serious and long-lasting complication of stem cell transplants. Researchers will follow over 600 people with chronic GVHD for several years, collecting detailed information from doctors and patients to test new national guidelines. The goal is to better predict patient outcomes and improve future clinical trials, not to test a new treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC GRAFT VERSUS HOST DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dana-Farber Cancer Institute
Boston, Massachusetts, 02115, United States
-
Fred Hutchinson Cancer Research Center
Seattle, Washington, 98109, United States
-
H. Lee Moffitt Cancer Center
Tampa, Florida, 33612, United States
-
Medical College of Wisconsin
Milwaukee, Wisconsin, 53226, United States
-
Memorial Sloan Kettering
New York, New York, 10065, United States
-
Stanford University
Stanford, California, 94305, United States
-
University of Minnesota
Minneapolis, Minnesota, 55455, United States
-
Vanderbilt University
Nashville, Tennessee, 37232, United States
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.